Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Nitrogen mustard prodrugs from CRC Technology

Sep. 20, 1996

Daiichi's anticancer drugs in development

Sep. 13, 1996

Chugai's anticancer R&D pipeline

Sep. 13, 1996

Expanded approval sought for Photofrin

Sep. 13, 1996

Cytoprotective agent receives broad approval in Australia

Sep. 13, 1996

DNA repair gene isolated

Sep. 13, 1996

Site-specific catalytic cleavage of RNA achieved with ribozyme analogue

Sep. 13, 1996

Dolastatin 10 mimic dolaphenine androstane

Sep. 13, 1996

Antitumor agents from Samjin

Sep. 13, 1996

Phase I trial of a new antiangiogenic agent from Daiichi

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...